TrialRadiology2018

Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial.

Savannah C Partridge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.